05/14/2025
11:15 AM | Avidity Biosciences (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
9:44 AM | Avidity Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
6:55 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:56 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
7:50 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
5:38 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:40 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:42 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:44 PM | Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:36 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
6:02 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for RNA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
03/12/2025
3:23 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:35 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
5:17 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:59 PM | Avidity Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
3:13 PM | Avidity Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
10:24 AM | Avidity Biosciences (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G | |
02/05/2025
4:01 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:34 PM | Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
7:12 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:14 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:15 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:17 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:06 PM | Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:08 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
7:10 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:25 PM | Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:35 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:22 PM | Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:24 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:26 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:29 PM | Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:31 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:13 PM | Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:14 PM | Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:16 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:52 PM | Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
6:04 PM | Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:42 PM | Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:46 PM | Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
8:02 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
How Trade Wars Are Creating Fresh Opportunities for Investors (Ad) Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity.
New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early.
That’s why we’ve just released our latest research:
📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio” Position yourself ahead of the next move—get the full report here. |
12/19/2024
5:15 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:15 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:16 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:17 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:46 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
5:08 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
3:59 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2024
5:06 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
5:10 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:46 PM | Avidity Biosciences (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
8:39 AM | Avidity Biosciences (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G | |
11/12/2024
6:06 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:50 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
12:56 PM | Avidity Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/04/2024
9:22 AM | Avidity Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/30/2024
7:01 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
3:19 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
3:21 PM | Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:20 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
12:48 PM | Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
4:23 PM | Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:02 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
3:36 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/23/2024
7:59 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
8:01 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
8:03 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
8:06 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:27 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
4:19 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:25 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:18 PM | Avidity Biosciences (Subject)
McCarthy Teresa (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:18 PM | Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
5:26 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:46 PM | Avidity Biosciences (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13D/A | |
08/21/2024
3:30 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:43 PM | Avidity Biosciences (Filer)
| Form 424B5 | |
08/15/2024
3:46 PM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:20 PM | Avidity Biosciences (Filer)
| Form 424B5 | |
08/09/2024
4:12 PM | Avidity Biosciences (Filer)
| Form 424B5 | |
08/09/2024
3:20 PM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
3:23 PM | Avidity Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
6:02 AM | Avidity Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
4:46 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:11 AM | Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:06 AM | Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/23/2024
3:22 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
5:47 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
5:48 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
5:49 PM | Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
5:47 PM | Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
$19 for a FULL YEAR of stock picks?! (Ad) Invest in Musk's AI Play With Just $100
You don't need deep pockets to ride the next wave of AI wealth.
Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock. Watch the exclusive AI investor briefing >>> |
06/14/2024
5:54 PM | Avidity Biosciences (Issuer)
Henig Noreen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:56 PM | Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:58 PM | Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:01 PM | Avidity Biosciences (Issuer)
BOESS CARSTEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:03 PM | Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:06 PM | Avidity Biosciences (Issuer)
Kim Jean Jinsun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:07 PM | Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
6:09 PM | Avidity Biosciences (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:52 PM | Avidity Biosciences (Issuer)
WILSON TROY EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy RNA Stock Free RNA Stock Alerts